Middle East Companion Animal Healthcare Market, by End User, 2018-2027
| Label | Therapeutics | Diagnostics |
|---|---|---|
| 2018 | 1568.7 USD Mn | 391.64 USD Mn |
| 2019 | 1685.65 USD Mn | 417.03 USD Mn |
| 2020 | 1793.26 USD Mn | 439.61 USD Mn |
| 2021 | 1938.72 USD Mn | 470.92 USD Mn |
| 2022 | 2099.7 USD Mn | 505.33 USD Mn |
| 2023 | 2278.18 USD Mn | 543.22 USD Mn |
| 2024 | 2476.43 USD Mn | 584.99 USD Mn |
| 2025 | 2697.05 USD Mn | 631.14 USD Mn |
| 2026 | 2943.05 USD Mn | 682.23 USD Mn |
| 2027 | 3217.88 USD Mn | 738.87 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the Middle East Companion Animal Healthcare Market, by Product, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 3625 Mn in 2026 and is projected to reach USD 3957 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
- What the regional split looks like (2026): Therapeutics leads, holding roughly 81% of segment value — the single largest regional share. Diagnostics is the second-largest contributor.
- By 2027, Therapeutics alone is expected to reach USD 3218 Mn, with Diagnostics at USD 739 Mn.
Market Dynamics
The Middle East companion animal healthcare market is expected to witness significant growth in the coming years due to various factors such as the increasing number of pet ownership, rise in disposable income, and growing awareness about animal health. The market is segmented based on product type, including pharmaceuticals, vaccines, parasiticides, nutritionals, and others.
The pharmaceutical segment is expected to dominate the market during the forecast period owing to the high demand for medicines for various diseases and infections in companion animals. This can be attributed to the rising cases of viral and bacterial diseases in pets, as well as the growing trend of pet humanization, which has resulted in an increase in demand for high-quality healthcare products for pets.
The vaccine segment is also expected to witness significant growth in the Middle East companion animal healthcare market. With the growing awareness about the importance of preventive healthcare in pets, the demand for vaccines is increasing significantly. Moreover, the development of advanced vaccines with minimal side effects is also contributing to the market growth.
Another important product in the companion animal healthcare market is parasiticides. These are used to treat and prevent parasitic infections in pets, such as fleas, ticks, and worms. With the increasing incidence of these infections, the demand for effective parasiticides is also rising, thereby driving the growth of this segment.
Nutritional products, such as vitamins, supplements, and specialized diets, are also gaining traction in the Middle East companion animal healthcare market. These products are important for the overall health and well-being of pets and are being increasingly recommended by veterinarians. The growing trend of pet humanization, with pet owners treating their pets like family members, is also contributing to the demand for high-quality nutritional products for pets.
In addition to these products, the market also includes various other healthcare products, such as dental care products, wound care products, and diagnostic products, which are essential for the proper management of companion animal health.
Overall, the Middle East companion animal healthcare market is witnessing growth due to the rising pet ownership and increasing awareness about the importance of pet health. The demand for high-quality and specialized healthcare products for pets is expected to drive the market in the coming years.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



